IOBT NASDAQ
IO Biotech, Inc.
1W: -33.2%
1M: -96.8%
3M: -98.8%
YTD: -99.1%
1Y: -99.3%
3Y: -99.7%
$0.01
Last traded 2026-04-20 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$849K
-12.3% ▼
Operating Income
-$95M
-4.1% ▼
Net Income
-$95M
-10.9% ▼
EPS (Diluted)
$-1.45
+26.8% ▲
EBITDA
-$93M
-2.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $540K | $756K | $849K |
| Gross Profit | $0 | $0 | -$540K | -$756K | -$849K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $8M | $30M | $47M | $68M | $71M |
| SG&A Expenses | $2M | $11M | $24M | $23M | $23M |
| Operating Expenses | $10M | $41M | $71M | $91M | $94M |
| Operating Income | -$10M | -$41M | -$71M | -$91M | -$95M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $26K | $361K | $302K | $0 | $0 |
| Income Before Tax | -$12M | -$68M | -$70M | -$85M | -$94M |
| Tax Expense | $0 | $68K | $1M | $852K | $1M |
| Net Income | -$12M | -$68M | -$71M | -$86M | -$95M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-1.05 | $-2.36 | $-2.48 | $-1.98 | $-1.45 |
| EBITDA | -$12M | -$67M | -$69M | -$84M | -$93M |
| Shares Outstanding | 12M | 29M | 29M | 44M | 66M |